Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study investigates if COVID-19 restrictions were associated with differences in health and lifestyle of Labradors

A new study investigated whether COVID-19 restrictions were associated with differences in Dogslife Labrador Retrievers' lifestyle.

15 Feb 2022

Study explores the generation of SARS-CoV-2 Omicron Spike DNA construct using multiple site-targeted mutagenesis

In a new study, a team of researchers demonstrated multiple site-directed mutagenesis as an efficient, easy, and more economically viable alternative to commercial gene synthesis to highlight how specific residues can contribute to the molecular structure and functioning of proteins.

15 Feb 2022

Study investigates whether SARS-CoV-2 infection is associated with increased risk of incident type 1 diabetes

A recent study has demonstrated that although the incidence of type 1 diabetes increases among children during the COVID-19 pandemic, previous infection by SARS-CoV-2 does not directly act as a causal factor.

15 Feb 2022

Scientists identify potential reasons for COVID-19 vaccine hesitancy in US among individuals with chronic health conditions

A recent survey conducted on the adult population in the United States has identified the most common predictive reasons behind COVID-19 vaccine hesitancy.

15 Feb 2022

Study describes sequelae presenting more than six months after COVID-19 in non-hospitalized young adults

A recent study described COVID-19 sequelae developed in non-hospitalized young adults more than six months after COVID-19 infection.

15 Feb 2022

Novel glycation patterns help understand Omicron immune escape

A new study explores changes in the sugar structure of the SARS-CoV-2 Omicron variant, which may shed light on its immunologic escape and transmissibility characteristics.

15 Feb 2022

South African population reveal durable protection by prior infection against pre-Omicron variants

A recent study explored the buildup of immunity developed post-SARS-CoV-2 infection in African people and the impact of SARS-CoV-2 Omicron VOC on the COVID-19 pandemic.

15 Feb 2022

Estimates of COVID-19 hospitalization and ICU burden from existing severe acute respiratory infections surveillance

Researchers estimated SARS-CoV-2 hospitalization and ICU treatment during the first three waves of the COVID-19 pandemic.

15 Feb 2022

Study explores SARS-CoV-2 antibodies in children

Researchers set out to explore how COVID-19 antibody responses persist over time after natural infection in children.

15 Feb 2022

Retrospective study estimates the substantial number of COVID-19 deaths among the unvaccinated

Researchers from the US performed a retrospective analysis to estimate excess COVID-19-associated deaths in the unvaccinated population of the US.

15 Feb 2022

Study suggests that epigenetic memory in innate immune cells could be the key to explaining long COVID

A new study may provide a partial explanation for the long-term immunologic phenomena associated with COVID-19.

15 Feb 2022

SARS-CoV-2 transmission in transmission pairs of school-aged children during the COVID-19 pandemic in the Netherlands

Researchers evaluated whether SARS-CoV-2 transmission among school-aged children in the Netherlands follows a bipartite school and household network.

15 Feb 2022

Producing more mRNA COVID vaccines could save 1.5M lives in low/middle-income countries

In a recent study posted to the medRxiv* preprint server, a team of researchers from the United States estimated the benefits of scaling up coronavirus disease 2019 (COVID-19) vaccination in the low- and lower-middle-income countries (LIC/LMICs) amid the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant using economic and epidemiological models linearized with public data of COVID-19 vaccinations and deaths.

15 Feb 2022

SARS-CoV-2 ORF6 inhibits mRNA export to favour viral translation and suppress innate signalling

A recent study posted to the bioRxiv* pre-print server investigated the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to inhibit the human immune response against viral infection.

15 Feb 2022

Cardiovascular markers for predicting clinical outcomes in SARS-CoV-2 infection

In a recent study posted to the medRxiv* preprint server, an interdisciplinary team of researchers from Toronto, Canada, characterized the markers of endothelial function and developed micro ribonucleic acid (miRNA) expression atlas in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive and -negative patients admitted to the intensive care unit (ICU).

15 Feb 2022

Study investigates the spread of SARS-CoV-2 genetic diversity on a fishing boat

In a recent study posted to the bioRxiv* preprint server, a team of researchers from Washington, United States, investigated the transmission of viral genetic diversity during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) superspreading outbreak among the crew members on a fishing boat.

14 Feb 2022

Antiviral potential of N-acylethanolamine acid amide hydrolase against SARS-CoV-2 and Zika virus

A recent study posted to the bioRxiv* pre-print server investigated the antiviral potential of N-acylethanolamine acid amidase (NAAA) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the Zika virus (ZIKV).

14 Feb 2022

Real-world data on efficacy and safety of COVID vaccines in Canada

In a recent study posted to the medRxiv* preprint server, researchers evaluated the efficacy and safety of the coronavirus disease 2019 (COVID-19) vaccines in young and elderly cohorts from Canada.

14 Feb 2022

First survey on Omicron BA.2 in France

In a recent study posted to the medRxiv* preprint server, researchers described the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 21L/BA.2 Omicron variant in south-eastern France.

14 Feb 2022

Phase one study of oral SARS-CoV-2 antiviral agent nirmatrelvir

A recent study posted to the medRxiv* preprint server reported the phase one pharmacokinetic and safety data of nirmatrelvir/ritonavir to facilitate its rapid progression to the last stages of clinical trials in coronavirus disease 2019 (COVID-19) patients with mild to moderate disease.

14 Feb 2022

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study investigates if COVID-19 restrictions were associated with differences in health and lifestyle of Labradors

Study explores the generation of SARS-CoV-2 Omicron Spike DNA construct using multiple site-targeted mutagenesis

Study investigates whether SARS-CoV-2 infection is associated with increased risk of incident type 1 diabetes

Scientists identify potential reasons for COVID-19 vaccine hesitancy in US among individuals with chronic health conditions

Study describes sequelae presenting more than six months after COVID-19 in non-hospitalized young adults

Novel glycation patterns help understand Omicron immune escape

South African population reveal durable protection by prior infection against pre-Omicron variants

Estimates of COVID-19 hospitalization and ICU burden from existing severe acute respiratory infections surveillance

Study explores SARS-CoV-2 antibodies in children

Retrospective study estimates the substantial number of COVID-19 deaths among the unvaccinated

Study suggests that epigenetic memory in innate immune cells could be the key to explaining long COVID

SARS-CoV-2 transmission in transmission pairs of school-aged children during the COVID-19 pandemic in the Netherlands

Producing more mRNA COVID vaccines could save 1.5M lives in low/middle-income countries

SARS-CoV-2 ORF6 inhibits mRNA export to favour viral translation and suppress innate signalling

Cardiovascular markers for predicting clinical outcomes in SARS-CoV-2 infection

Study investigates the spread of SARS-CoV-2 genetic diversity on a fishing boat

Antiviral potential of N-acylethanolamine acid amide hydrolase against SARS-CoV-2 and Zika virus

Real-world data on efficacy and safety of COVID vaccines in Canada

First survey on Omicron BA.2 in France

Phase one study of oral SARS-CoV-2 antiviral agent nirmatrelvir

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in